Uniphos Enterprises
Ticker > Company >

Uniphos Enterprises share price

Uniphos Enterprises Ltd.

NSE: UNIENTER BSE: 500429 SECTOR: Trading  25.55 K   19   3

153.65
-1.35 (-0.87%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 156.45

Today's Low

₹ 153.65

52 Week High

₹ 194

52 Week Low

₹ 123.1

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 1068.57 Cr.

Enterprise Value

₹ 1052.5 Cr.

No. of Shares

6.95 Cr.

P/E

0

P/B

0.41

Face Value

₹ 2

Div. Yield

0.33 %

Book Value (TTM)

₹  373.27

CASH

₹ 16.07 Cr.

DEBT

₹ 0 Cr.

Promoter Holding

73.79 %

EPS (TTM)

₹  -0.04

Sales Growth

120.17%

ROE

0.01 %

ROCE

0.07%

Profit Growth

-99.28 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year120.17%
3 Year350.23%
5 Year245.41%

Profit Growth

1 Year-99.28%
3 Year-82.79%
5 Year-57.5%

ROE%

1 Year0.01%
3 Year0.99%
5 Year1.23%

ROCE %

1 Year0.07%
3 Year1.01%
5 Year1.23%

Debt/Equity

0

Price to Cash Flow

-393.31

Interest Cover Ratio

1.1722

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 73.79 0.00
Mar 2025 73.79 0.00
Dec 2024 73.79 0.00
Sep 2024 73.79 0.00
Jun 2024 73.79 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 350.228571253155% for the Past 3 years.
  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of -3.6624 days.
  • Company has a healthy liquidity position with current ratio of 8.8321.
  • The company has a high promoter holding of 73.79%.

 Limitations

  • The company has shown a poor profit growth of -82.7906799489578% for the Past 3 years.
  • Company has a poor ROE of 0.986433333333333% over the past 3 years.
  • Company has a poor ROCE of 1.01413333333333% over the past 3 years
  • Company has negative cash flow from operations of -2.7169.
  • The company has a low EBITDA margin of -165.572561489741% over the past 5 years.
  • The company is trading at a high PE of 0.
  • The company is trading at a high EV/EBITDA of 622.4141.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 3.03 30.48 5.1 72.9 5.86
Total Expenditure 3.78 30.96 6.1 74.5 6.69
Operating Profit -0.75 -0.48 -1 -1.59 -0.83
Other Income 0.79 4.67 0.45 0.21 0.27
Interest 0 0.14 1.17 0 0
Depreciation 0.19 0.19 0.19 0.19 0.17
Exceptional Items 0 0 0 0 0
Profit Before Tax -0.15 3.86 -1.91 -1.58 -0.74
Tax 0 0 -0.05 0 0
Profit After Tax -0.15 3.86 -1.86 -1.58 -0.74
Adjusted EPS (Rs) -0.02 0.56 -0.27 -0.23 -0.11

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 0.83 1.22 1.47 50.65 111.51
Total Expenditure 3.9 4.35 4.33 53.74 115.33
Operating Profit -3.06 -3.13 -2.86 -3.09 -3.82
Other Income 26.5 57.1 43.09 42.87 6.12
Interest 0 0 0 0 1.32
Depreciation 0.03 0.03 0.6 0.83 0.75
Exceptional Items 0 0 0 0 0
Profit Before Tax 23.4 53.94 39.62 38.94 0.23
Tax -1.05 -0.67 0.4 0.33 -0.05
Net Profit 24.45 54.6 39.23 38.61 0.28
Adjusted EPS (Rs.) 3.52 7.85 5.64 5.55 0.04

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 13.91 13.91 13.91 13.91 13.91
Total Reserves 2700.8 3166.62 2983.69 2061.54 2727.74
Borrowings 0 0 0 0 0
Other N/C liabilities 56.64 120.44 96.81 -21.46 98.22
Current liabilities 0.26 0.6 1.06 2.05 1.84
Total Liabilities 2771.61 3301.57 3095.47 2056.04 2841.71
Assets
Net Block 0 0 0 0 0
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 2509.2 3042.82 2836.33 1802.5 2615.48
Loans & Advances 26.27 23.57 22.05 22.4 22.63
Other N/C Assets 175.54 175.5 183.92 183.09 187.34
Current Assets 60.61 59.68 53.16 48.05 16.26
Total Assets 2771.61 3301.57 3095.47 2056.04 2841.71
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 23.4 53.94 39.62 38.94 0.23
Adjustment -26.46 -57.06 -42.48 -42.03 -3.03
Changes in Assets & Liabilities -0.51 0.28 0.28 0.3 0.26
Tax Paid -1.01 3.37 1.12 -0.68 -0.18
Operating Cash Flow -4.59 0.52 -1.47 -3.47 -2.72
Investing Cash Flow -33.86 20.43 40.63 50.16 52.77
Financing Cash Flow 0 -23.65 -39.29 -45.2 -40.96
Net Cash Flow -38.45 -2.69 -0.13 1.49 9.09

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 73.79 73.79 73.79 73.79 73.79
nerka chemicals pvt ltd 73.29 73.29 73.29 73.29 73.28
r shroff consultants priv... 0.01 0.01 0.01 0.01 0.01
sandra rajnikant shroff 0.01 0.01 0.01 0.01 0.01
shilpa p sagar 0.47 0.47 0.47 0.47 0.47
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 26.21 26.21 26.21 26.21 26.21
acacia institutional part... 1.04 1.04 1.04 1.04 1.04
acacia partners, lp 1.31 1.31 1.31 1.31 1.31
ares diversified 4.56 4.56 4.56 4.56 4.56
arial holdings 1 1.35 2.69 2.69 2.69 2.69
gaurav n lodha 1.59 1.60 1.60 1.69 1.74
gymkhana partners l.p. 1.03 1.03 1.03 1.03 1.03
llp - - 0.01 0.01 0.01
resonance opportunities f... 3.65 3.65 3.65 3.65 3.65
eos multi-strategy fund a... 1.34 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Uniphos Enterprises informs about newspaper publications 21 Aug, 3:50 PM Uniphos Enterprises informs about AGM 18 Aug, 3:57 PM Uniphos Enterprises - Quaterly Results 13 Aug, 4:26 PM Uniphos Enterprises - Quaterly Results 13 Aug, 4:26 PM Uniphos Enterprises - Quaterly Results 13 Aug, 4:26 PM Uniphos Enterprises informs about compliances certificate 9 Jul, 5:32 PM Uniphos Enterprises informs about closure of trading window 30 Jun, 1:08 PM Uniphos Enterprises - Quaterly Results 28 May, 7:41 PM Uniphos Enterprises - Quaterly Results 28 May, 7:41 PM Uniphos Enterprises - Quaterly Results 13 Feb, 4:40 PM Uniphos Enterprises - Quaterly Results 13 Feb, 4:40 PM Uniphos Enterprises informs about certificate 7 Jan, 12:43 PM Uniphos Enterprises informs about trading window closure 30 Sep, 12:45 PM Uniphos Enterprises informs about newspaper publications 28 Aug, 11:06 AM Uniphos Enterprises informs about newspaper publications 14 Aug, 12:38 PM Uniphos Enterprises - Quaterly Results 13 Aug, 4:42 PM Uniphos Enterprises - Quaterly Results 13 Aug, 4:42 PM Uniphos Enterprises - Quaterly Results 28 May, 5:19 PM Uniphos Enterprises - Quaterly Results 28 May, 5:19 PM Uniphos Enterprises informs about loss of share certificates 6 Mar, 4:00 PM Uniphos Enterprises - Quaterly Results 13 Feb, 4:52 PM Uniphos Enterprises - Quaterly Results 13 Feb, 4:52 PM Uniphos Enterprises - Quaterly Results 8 Nov, 4:25 PM Uniphos Enterprises - Quaterly Results 9 Aug, 4:04 PM Uniphos Enterprises - Quaterly Results 9 Aug, 4:04 PM Uniphos Enterprises - Quaterly Results 9 Aug, 4:04 PM Uniphos Enterprises informs about newspaper publication 28 Jul, 4:33 PM Uniphos Enterprises informs about disclosure of related party transactions 27 May, 9:54 AM Uniphos Enterprises - Quaterly Results 26 May, 5:32 PM Uniphos Enterprises - Quaterly Results 26 May, 5:32 PM Uniphos Enterprises - Quaterly Results 14 Feb, 11:39 AM Uniphos Enterprises - Quaterly Results 14 Feb, 11:39 AM Uniphos Enterprises informs about issuance of letters of confirmation 6 Dec, 4:57 PM Uniphos Enterprises - Quaterly Results 14 Nov, 4:51 PM Uniphos Enterprises - Quaterly Results 14 Nov, 4:51 PM Uniphos Enterprises informs about loss of share certificate 21 Oct, 1:00 PM Uniphos Enterprises informs about loss of share certificate 19 Aug, 12:32 PM Uniphos Enterprises - Quaterly Results 12 Aug, 3:49 PM Uniphos Enterprises - Quaterly Results 12 Aug, 3:49 PM Uniphos Enterprises - Quaterly Results 24 May, 3:47 PM Uniphos Enterprises - Quaterly Results 24 May, 3:47 PM Uniphos Enterprises - Quaterly Results 24 May, 3:47 PM Uniphos Enterprises - Quaterly Results 7 Feb, 4:16 PM Uniphos Enterprises - Quaterly Results 7 Feb, 4:16 PM Uniphos Enterprises - Quaterly Results 7 Feb, 4:16 PM Uniphos Enterprises informs about trading window closure 31 Dec, 12:28 PM Uniphos Enterprises informs about board meeting 3 Nov, 12:29 PM Uniphos Enterprises informs about certificate 7 Oct, 9:42 AM Uniphos Enterprises informs about trading window closure 29 Sep, 3:18 PM Uniphos Enterprises informs about loss of share certificates 22 Sep, 9:57 AM

Uniphos Enterprises Stock Price Analysis and Quick Research Report. Is Uniphos Enterprises an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Uniphos Enterprises. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Uniphos Enterprises has a PE ratio of -3442.31625835189 which is low and comparatively undervalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Uniphos Enterprises has ROA of 0.0114% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Uniphos Enterprises has a Current ratio of 8.8321.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Uniphos Enterprises has a ROE of 0.0123%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Uniphos Enterprises has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

  • Sales growth: Uniphos Enterprises has reported revenue growth of 120.1696% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Uniphos Enterprises for the current financial year is -3.42530308587561%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Uniphos Enterprises is Rs 0.5 and the yield is 0.3254%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Uniphos Enterprises is Rs -0.0449. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Uniphos Enterprises in Ticker for free. Also, one can get the intrinsic value of Uniphos Enterprises by using Valuation Calculators, which are available with a Finology ONE subscription. 

Uniphos Enterprises FAQs

Q1. What is Uniphos Enterprises share price today?
Ans: The current share price of Uniphos Enterprises is Rs 154.56.

Q2. What is the market capitalisation of Uniphos Enterprises?
Ans: Uniphos Enterprises has a market capitalisation of Rs 1074.900642144 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Uniphos Enterprises?
Ans: The PE ratio of Uniphos Enterprises is -3442.31625835189 and the P/B ratio of Uniphos Enterprises is 0.414074237595455, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Uniphos Enterprises share?
Ans: The 52-week high share price of Uniphos Enterprises is Rs 192.68, and the 52-week low share price of Uniphos Enterprises is Rs 129.44.

Q5. Does Uniphos Enterprises pay dividends?
Ans: Currently, Uniphos Enterprises pays dividends. Dividend yield of Uniphos Enterprises is around 0.3254%.

Q6. What are the face value and book value of Uniphos Enterprises shares?
Ans: The face value of Uniphos Enterprises shares is Rs 2, while the book value per share of Uniphos Enterprises is around Rs 373.2664. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Uniphos Enterprises?
Ans: Uniphos Enterprises has a total debt of Rs 0 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Uniphos Enterprises?
Ans: The ROE of Uniphos Enterprises is 0.0123% and ROCE of Uniphos Enterprises is 0.0682%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Uniphos Enterprises a good buy for the long term?
Ans: The Uniphos Enterprises long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Uniphos Enterprises undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Uniphos Enterprises appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Uniphos Enterprises’s financials?
Ans: You can review Uniphos Enterprises’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Uniphos Enterprises

Uniphos Enterprises Limited Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Uniphos Enterprises Limited (UEL) is a leading manufacturer and distributor of analytical equipment, gas detection equipment, and environmental monitoring devices. Established in 1969, UEL has been providing quality solutions to various industries in India and around the world. With an experienced management team and robust R&D capabilities, UEL has been able to stay ahead of the curve and maintain a strong foothold in the market.

Uniphos Enterprises Limited: Share Price

As an investor, the share price is one of the key indicators that you keep an eye on. At UEL, we understand the importance of this metric, and that's why we offer a comprehensive page that provides regular updates on the share price. This page also includes our pre-built screening tools to help you filter stocks based on specified parameters, such as market cap and P/E ratio.

Uniphos Enterprises Limited: Balance Sheet

The Balance Sheet provides a snapshot of a company's financial health at a given point in time. As a long-term investor, it is imperative to keep track of UEL's financials, including its Balance Sheet. At UEL, we offer an in-depth analysis of the company's Balance Sheet, including its assets, liabilities, and equity. Additionally, our premium features enable fair value calculation of the stock using tools such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis.

Uniphos Enterprises Limited :  Annual Report

UEL's Annual Report is a comprehensive document that provides stakeholders with information about the company's performance over the past year. It includes financial statements, management analysis, market analysis, and other relevant information. At UEL, we provide Annual Reports as downloadable PDFs on our website, making it easy for investors to access this important information.

Uniphos Enterprises Limited : Dividend

Dividend payouts are an essential metric for investors looking for long-term growth. UEL has a history of consistent dividend payouts, making it an attractive option for investors looking for stable returns. At UEL, we offer a comprehensive page that tracks the company's dividend payouts and yield.

Uniphos Enterprises Limited : Quarterly Result

Quarterly results provide investors with an overview of the company's financial performance over the previous three months. At UEL, we provide regular updates on the company's quarterly results, including revenues, net profit, and EPS. Additionally, our premium features enable fair value calculation of the stock using tools such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis.

Uniphos Enterprises Limited : Stock Price

The Stock Price page provides a comprehensive overview of UEL's share price over time. Investors can view the stock's historical performance, track its progress over the past few months, and get real-time updates. Additionally, our pre-built screening tools enable investors to filter stocks based on specified parameters, such as market cap and P/E ratio.

Uniphos Enterprises Limited : Price Chart

The Price Chart page provides investors with a graphical representation of UEL's stock price over time. This page includes our pre-built screening tools, which allow investors to filter stocks based on specified parameters. Additionally, our premium features enable fair value calculation of the stock using tools such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis.

Uniphos Enterprises Limited :News

The News page provides investors with real-time updates on UEL. Our team of experts closely monitors the market, providing timely and relevant news updates. This page includes our pre-built screening tools, which allow investors to filter stocks based on specified parameters, such as market cap and P/E ratio.

Uniphos Enterprises Limited :  Concall

The Concall Transcripts page provides investors with transcripts from UEL's conference calls. This page includes our pre-built screening tools, which allow investors to filter stocks based on specified parameters, such as market cap and P/E ratio. Additionally, our premium features enable fair value calculation of the stock using tools such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis.

Uniphos Enterprises Limited : Investor Presentations

UEL's Investor Presentations page provides investors with a comprehensive overview of the company's strategy and future plans. This page includes presentations from senior management, explaining the company's vision, its growth trajectory, and its plans for innovation and expansion. Additionally, our premium features enable fair value calculation of the stock using tools such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis.

Uniphos Enterprises Limited :  Promoters

UEL's Promoters are the individuals or entities that hold a significant stake in the company. These individuals or entities are crucial in setting the company's direction and strategy. At UEL, we offer an in-depth analysis of the company's Promoters, including their backgrounds, experience, and contribution to the company's growth.

Uniphos Enterprises Limited :  Shareholders

At UEL, we understand the importance of Shareholders in shaping a company's growth trajectory. That's why we provide a comprehensive analysis of UEL's Shareholders, including their backgrounds, contribution to the company's growth, and shareholding patterns. Additionally, our premium features enable fair value calculation of the stock using tools such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis.

In conclusion, UEL is a leading manufacturer and distributor of analytical and environmental monitoring devices. As a long-term investor, it is essential to keep track of the company's financial health, including its Balance Sheet, Annual Report, Dividend payouts, and Quarterly Results. At UEL, we offer comprehensive analysis on these metrics, along with pre-built screening tools and premium features for fair value calculation of the stock. Additionally, we provide real-time updates on the company's Stock Price, Price Chart, News, Concall Transcripts, and Investor Presentations, making it a one-stop-shop for investors. 

Uniphos Enterprises Balance Sheet Overview

Analyzing the balance sheet of Uniphos Enterprises over a span of five years, from March 2020 to March 2024, a clear picture emerges of the company's financial position. The equity and liabilities section shows a steady share capital figure of Rs 13.91 Cr throughout the period; however, the total reserves have seen a fluctuation, peaking at Rs 3,166.62 Cr in March 2022 before falling to Rs 2,061.54 Cr by March 2024.

Uniphos Enterprises Reserves Trend

The company's reserves have experienced notable changes. A sharp increase in reserves was observed from March 2020, at Rs 1,503.90 Cr, to March 2021 with Rs 2,700.80 Cr. This increment continued, albeit at a slower pace, to Rs 3,166.62 Cr in March 2022. However, from March 2022 onwards, the reserves have decreased, settling at Rs 2,061.54 Cr in March 2024.

Uniphos Enterprises Debt Analysis

Uniphos Enterprises has demonstrated a robust financial structure with zero borrowings throughout the observed period. This indicates a strong solvency position and a potential preference for equity financing over debt.

Uniphos Enterprises Asset Management

On the assets side, investments form the cornerstone, with a significant proportion of total assets. The value of investments peaked at Rs 3,042.82 Cr in March 2022 and then declined to Rs 1,802.50 Cr by March 2024. Current assets have seen a slight decrease over the years, indicating a potential reduction in liquid assets.

The data provides an analysis for the Standalone Balance sheet of the company. Decisions regarding stocks always require careful evaluation of market trends, including NSE BSE indices, and sector-specific movements, which can provide deeper insights into a company's standing.

*Please note that all figures are presented in Rs Cr.

Read More
X